J Symonds

780 total citations · 1 hit paper
15 papers, 546 citations indexed

About

J Symonds is a scholar working on Epidemiology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, J Symonds has authored 15 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 4 papers in Infectious Diseases and 3 papers in Molecular Medicine. Recurrent topics in J Symonds's work include Antibiotic Resistance in Bacteria (3 papers), Urinary Tract Infections Management (3 papers) and Bacteriophages and microbial interactions (2 papers). J Symonds is often cited by papers focused on Antibiotic Resistance in Bacteria (3 papers), Urinary Tract Infections Management (3 papers) and Bacteriophages and microbial interactions (2 papers). J Symonds collaborates with scholars based in United Kingdom and Canada. J Symonds's co-authors include Y Arabi, Joel D. Brown, D. W. Burdon, R.H. George, J Alexander-Williams, M R B Keighley, N Shinagawa, Mike Bennett, Yi‐Cheng Tai and D. S. Reeves and has published in prestigious journals such as Pain, Journal of Antimicrobial Chemotherapy and Drugs.

In The Last Decade

J Symonds

13 papers receiving 481 citations

Hit Papers

Identification of Clostridium difficile as a cause of pse... 1978 2026 1994 2010 1978 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Symonds United Kingdom 8 357 174 85 67 57 15 546
R. P. Jechorek United States 9 159 0.4× 82 0.5× 155 1.8× 56 0.8× 63 1.1× 13 469
Ana María Guzmán Chile 12 213 0.6× 173 1.0× 203 2.4× 54 0.8× 29 0.5× 28 661
B. Pron France 13 236 0.7× 221 1.3× 135 1.6× 114 1.7× 82 1.4× 16 875
Finegold Sm United States 13 121 0.3× 113 0.6× 65 0.8× 63 0.9× 55 1.0× 42 439
C. Watanakunakorn United States 11 227 0.6× 159 0.9× 78 0.9× 55 0.8× 65 1.1× 17 515
A. Scarcella Italy 12 141 0.4× 156 0.9× 63 0.7× 77 1.1× 47 0.8× 17 517
S. Want United Kingdom 12 242 0.7× 137 0.8× 236 2.8× 56 0.8× 139 2.4× 20 692
Júlia Hermes Germany 11 281 0.8× 150 0.9× 161 1.9× 41 0.6× 39 0.7× 22 585
Rémi Le Guern France 14 183 0.5× 134 0.8× 144 1.7× 30 0.4× 71 1.2× 34 503
J M García-Arenzana Spain 14 210 0.6× 156 0.9× 101 1.2× 19 0.3× 69 1.2× 27 545

Countries citing papers authored by J Symonds

Since Specialization
Citations

This map shows the geographic impact of J Symonds's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Symonds with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Symonds more than expected).

Fields of papers citing papers by J Symonds

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Symonds. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Symonds. The network helps show where J Symonds may publish in the future.

Co-authorship network of co-authors of J Symonds

This figure shows the co-authorship network connecting the top 25 collaborators of J Symonds. A scholar is included among the top collaborators of J Symonds based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Symonds. J Symonds is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Lynch, Garrett R., Steven Walker, J Symonds, et al.. (2025). S35 Reducing repeat pleural biopsies in suspected mesothelioma (REPLICA). A30.2–A31.
3.
Symonds, J, et al.. (1998). Helicobacter pylori. Anaesthesia. 53(2). 209–210.
4.
Symonds, J. (1998). Urinary Tract Infections. Journal of the Royal Society of Medicine. 91(10). 558–559. 11 indexed citations
5.
Symonds, J. (1997). Escherichia Coli: Mechanisms of Virulence. Journal of the Royal Society of Medicine. 90(8). 466–466. 85 indexed citations
6.
Das, I. & J Symonds. (1996). Endophthalmitis. Reviews in Medical Microbiology. 7(3). 133–142. 1 indexed citations
7.
Das, I., et al.. (1996). Pyomyositis: an unusual infection due to staphylococcus aureus.. PubMed. 41(3). 182–3. 5 indexed citations
8.
Bennett, Mike, Yi‐Cheng Tai, & J Symonds. (1994). Staphylococcal meningitis following synchromed intrathecal pump implant: A case report. Pain. 56(2). 243–244. 42 indexed citations
9.
Symonds, J, et al.. (1988). The penetration of ofloxacin into bronchial secretions. Journal of Antimicrobial Chemotherapy. 22(Supplement_C). 91–95. 12 indexed citations
10.
Symonds, J, et al.. (1987). Penetration of Ofloxacin into Bronchial Secretions. Drugs. 34(Supplement 1). 33–36. 8 indexed citations
11.
Symonds, J. (1984). Oral or parenteral antibiotic treatment in serious infections.. Archives of Disease in Childhood. 59(6). 501–503. 1 indexed citations
12.
Symonds, J. (1979). Secnidazole—a nitroimidazole with a prolonged serum half-life. Journal of Antimicrobial Chemotherapy. 5(4). 484–486. 9 indexed citations
13.
George, R.H., J Symonds, Joel D. Brown, et al.. (1978). Identification of Clostridium difficile as a cause of pseudomembranous colitis.. BMJ. 1(6114). 695–695. 354 indexed citations breakdown →
14.
Wise, Robert I., D. S. Reeves, J Symonds, & P. J. Wilkinson. (1976). A Clinical Investigation of Pivmecillinam. Chemotherapy. 22(5). 335–339. 7 indexed citations
15.
Wise, Robert A., D. S. Reeves, J Symonds, & P. J. Wilkinson. (1976). A Clinical Investigation of Pivmecillinam, a Novel ß-Lactam Antibiotic, in the Treatment of Urinary Tract Infections. 205–210. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026